When?
Where?
EuroClonality Workshop | Clonality Assessment in Pathology 3-5 March 2027 Nijmegen, The Netherlands
Central in the workshop are the discussions of cases that the participants bring themselves. The cases are discussed from the different professionals views (morphology, molecular and clinical context), resulting in interprofessional learning. The cases are used on a hands-on basis; using microscopic views for pathology evaluation and clonality results for interpretation.
The workshops are for a restricted number of persons. We invite persons to the workshop:
- who use the EuroClonality/BIOMED-2 primers and protocols or the EuroClonality NGS-based clonality
- who are able to bring cases for evaluation during the workshop
- who participate as combination of pathology (or flow cytometry) and molecular biology; only a combination of two persons per institute will be accepted for the workshop.
With this background, we are convinced that the workshops are a fruitful experience that will lead to improved diagnosis of malignant lymphomas.
Workshop Faculty
- Dr. Patricia Groenen, clinical scientist in molecular pathology, Radboudumc, Nijmegen, NL, workshop coordinator
- Prof. dr. Falko Fend, hematopathologist, University of Tübingen, DE
- Prof. dr. Ton Langerak, medical immunologist, Erasmus MC, Rotterdam, NL
Registration
The registration form, including personal details and descriptions of the cases to be submitted, must be received by the Workshop Secretariat [email protected] no later than 6 November 2026. Without submitted case descriptions via the registration form, your registration cannot be accepted. Registrants will be informed about their provisional acceptance for the workshop before 24 November 2026.
The registration fee for participation in the workshop is €415, which should be paid after provisional acceptance and receipt of an invoice (which will be sent via email).
Participants will be accepted only when the registration fee has been received by Radboudumc before 19 January 2027. Participants will be informed about their final acceptance no later than 22 January 2027.